United States Views

Pages

Agenus Completes 4-Antibody Acquisition

Agenus, a company developing novel immunotherapeutics, including a portfolio of checkpoint modulators (CPMs), anticancer vaccines and adjuvants, has completed its previously announced acquisition of...

Read article ›

Pages